Therapeutic Asset Ratings
394 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DEXAMETHASONE
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Favezelimab
Metastatic Neoplasm
Merck Sharp & Dohme LLC
P1/2
CC
(43)
her3-dxd
Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Intismeran
Urinary Bladder Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Levoleucovorin
Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Lorazepam
Biliary Tract Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(43)
mk-1045
Non-Hodgkin Lymphoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Patritumab Deruxtecan
Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Sacituzumab Tirumotecan
Biliary Tract Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Sacituzumab Tirumotecan
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Sacituzumab Tirumotecan
Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Vibostolimab
Metastatic Neoplasm
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Zilovertamab Vedotin
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC
P1/2
CC
(43)
Axitinib
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC
P1
CC
(42)
CARTIA
Prostate Neoplasm
Merck Sharp & Dohme LLC
P1
CC
(42)
Elpipodect
Alzheimer Disease
Merck Sharp & Dohme LLC
P1
CC
(42)
human hyaluronidase isozyme-5 (HYAL5, sperm adhesion molecule 1, SPAM1, hyaluronidase PH-20, EC:3.2.1.35) fragment (3-433, 1-431 in the current sequence) engineered variant with the structural domain replaced by the corresponding region of human hyaluronidase isozyme-1 (HYAL1)(<sup>306</sup>TLSIMRSMKSCLLDDNYMETI<sup>326</sup>><sup>304</sup>SWENTRTKESCQAIKEYMDTT<sup>324</sup>), produced in Chinese hamster ovary (CHO) cells, cell line DG44, glycoform alfa
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC
P1
CC
(42)
mk-1708
Alzheimer Disease
Merck Sharp & Dohme LLC
P1
CC
(42)
mk-5684
Prostate Neoplasm
Merck Sharp & Dohme LLC
P1
CC
(42)
mk-6598
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC
P1
CC
(42)
mk-1200
Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(42)
mk-4716
Cancer
Merck Sharp & Dohme LLC
P1
CC
(41)
mk-4884
Cancer
Merck Sharp & Dohme LLC
P1
CC
(41)
Belzutifan
Metastatic Prostate Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(41)
Showing 351 to 375 of 394 assets
Previous
Page 15 of 16
Next